Literature DB >> 17077282

The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis.

R Mentaverri1, S Yano, N Chattopadhyay, L Petit, O Kifor, S Kamel, E F Terwilliger, M Brazier, E M Brown.   

Abstract

Intracellular transduction pathways that are dependent on activation of the CaR by Ca(o)2+ have been studied extensively in parathyroid and other cell types, and include cytosolic calcium, phospholipases C, A2, and D, protein kinase C isoforms and the cAMP/protein kinase A system. In this study, using bone marrow cells isolated from CaR-/- mice as well as DN-CaR-transfected RAW 264.7 cells, we provide evidence that expression of the CaR plays an important role in osteoclast differentiation. We also establish that activation of the CaR and resultant stimulation of PLC are involved in high Ca(o)2+-induced apoptosis of mature rabbit osteoclasts. Similar to RANKL, Ca(o)2+ (20 mM) appeared to trigger rapid and significant nuclear translocation of NF-kappaB in a CaR- and PLC-dependent manner. In summary, our data suggest that stimulation of the CaR may play a pivotal role in the control of both osteoclast differentiation and apoptosis in the systems studied here through a signaling pathway involving activation of the CaR, phospholipase C, and NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077282     DOI: 10.1096/fj.06-6304fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  46 in total

1.  Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover.

Authors:  Melita M Dvorak-Ewell; Tsui-Hua Chen; Nathan Liang; Caitlin Garvey; Betty Liu; Chialing Tu; Wenhan Chang; Daniel D Bikle; Dolores M Shoback
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

Review 2.  Calcium signaling in osteoclasts.

Authors:  Sung-Yong Hwang; James W Putney
Journal:  Biochim Biophys Acta       Date:  2010-11-11

3.  Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation.

Authors:  Shuying Yang; Wei Chen; Philip Stashenko; Yi-Ping Li
Journal:  J Cell Sci       Date:  2007-10-01       Impact factor: 5.285

Review 4.  Regulation of osteoclast polarization.

Authors:  Naoyuki Takahashi; Sadakazu Ejiri; Shigeru Yanagisawa; Hidehiro Ozawa
Journal:  Odontology       Date:  2007-07-25       Impact factor: 2.634

Review 5.  The calcium-sensing receptor in bone.

Authors:  Toru Yamaguchi
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

Review 6.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

7.  Increased PTHrP and decreased estrogens alter bone turnover but do not reproduce the full effects of lactation on the skeleton.

Authors:  Laleh Ardeshirpour; Susan Brian; Pamela Dann; Joshua VanHouten; John Wysolmerski
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

8.  Parathyroid hormone-related protein overexpression protects goat mammary gland epithelial cells from calcium-sensing receptor activation-induced apoptosis.

Authors:  Hui Li; Yongsen Sun; Huiling Zheng; Lihui Li; Qian Yu; Xiaotong Yao
Journal:  Mol Biol Rep       Date:  2014-09-30       Impact factor: 2.316

9.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

10.  The calcimimetic R-568 induces apoptotic cell death in prostate cancer cells.

Authors:  Huaifu Li; Guofeng Ruan; Zhijun Li; Ziwei Liu; Xiaoqing Zheng; Hao Zheng; Guangming Cheng; Benyi Li; Ming Zhan
Journal:  J Exp Clin Cancer Res       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.